EGFR and non-small cell lung carcinoma: Since EGFR-TKIs induce less skin toxicity than EGFR antibodies, patients with NSCLC harboring EGFR mutations are generally treated only with preventative moisturizers, and with reactive oral minocycline and topical steroids only at the onset of the rash.